SCHEMBL6180664

SCHEMBL6180664

COc1cc2ncnc(-c3ccc(O)cc3)c2cc1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 4/20 0.61
RET P07949 8/20 0.60
KDR P35968 8/20 0.60
EGFR P00533 2/20 0.60
GAK O14976 1/20 0.60
RIPK2 O43353 1/20 0.60
STK10 O94804 1/20 0.60
FLT3 P36888 1/20 0.60
JAK3 P52333 1/20 0.60
AAK1 Q2M2I8 1/20 0.60
Q6ZSR9 Q6ZSR9 1/20 0.60
SLK Q9H2G2 1/20 0.60
IRAK4 Q9NWZ3 1/20 0.60
RPS6KA6 Q9UK32 1/20 0.60
ALK Q9UM73 1/20 0.60
LCK P06239 1/20 0.59
KIF5B P33176 7/20 0.52
PDGFRB P09619 1/20 0.51
PDGFRA P16234 1/20 0.51
ENPP1 P22413 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6180673 0.98 EGFR (0.61) KITRETKDREGFRGAK
SCHEMBL5569432 0.85 KIT (0.69) KITRETKDREGFRLCK
SCHEMBL182955 0.85 PIK3CD (0.61) KITPDGFRBPDGFRARAF1BRAF
SCHEMBL4782102 0.84 WHR1 (0.61) KITRETKDREGFRLCK
SCHEMBL23726135 0.84 KIT (0.57) KITRETKDREGFRGAK
SCHEMBL30079943 0.84 KIT (0.57) KITRETKDREGFRGAK
SCHEMBL22164766 0.84 KIT (0.57) KITEGFRLCKENPP1PDK1
SCHEMBL4726982 0.83 KIT (0.59) KITRETKDREGFRFLT3
SCHEMBL22300110 0.82 KIT (0.55) KITEGFRENPP1PDK1
SCHEMBL182593 0.82 PIK3CD (0.64) KITPDGFRBPDGFRARAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0871448-B1 ARYL AND HETEROARYL QUINAZOLINE COMPOUNDS WHICH INHIBIT CSF-1R RECEPTOR TYROSINE KINASE AVENTIS PHARMA INC (US) 2005-03-02 EP claimed
US-RE37650-E1 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase AVENTIS PHARMACETICAL PRODUCTS, INC. 2002-04-09 US claimed
US-5710158-A INHIBITORS OF PROTEIN TYROSINE KINASE AND EPIDERMAL GROWTH FACTOR RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-01-20 US claimed
CN-1100540-C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties AVENTIS PHARMA INC (US) 2003-02-05 CN disclosed
CN-1187129-A Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties RHONE POULENC RORER PHARMA (US) 1998-07-08 CN disclosed